Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Ointment on Endotracheal Tubes to Reduce Emergence Bucking
NCT07709390Phase 1Recruiting
- Sponsor
- The Ohio State University
- Start
- May 2023
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in 19p13.3 microduplication syndrome (2 arms), sponsored by The Ohio State University. Primary endpoint: Incidence of Coughing or Bucking During Emergence from General Anesthesia. Started May 2023; status: recruiting.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
19p13.3 microduplication syndrome
Beyond the preview
Go deeper on NCT07709390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07709390.